Search
for
Sort by
Research 31–60 of 722
- Novel causes of drug-induced occupational asthma
- HANSRAJ (Adiantum capillus-veneris) -A REVIEW
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Psoriasis
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Targets to treat androgen excess in polycystic ovary syndrome
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Hair Follicles: Strategic Targets for Promoting Hair Growth
- Effects of local and systemic medications on eye health: Adverse reactions
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- 10.51847/ubmwCM2
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Principles of Therapy of Skin Diseases
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Adverse Cutaneous Reactions to Antipsychotics
- Polycystic ovary syndrome: A review for dermatologists
- Insulin resistance and the long-term consequences of polycystic ovary syndrome
- Systemic causes of hair loss
- Dermatologic Problems of Older Women
- Pharmacological management of polycystic ovary syndrome
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Women’s Health Considerations for Lipid Management
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Amitriptyline-induced Telogen Effluvium in a Patient with Cervical Disc Prolapse: A Case Report